The best indicator for Exelon (EXC)
We backtested 20 indicators across daily, weekly and hourly charts on real Exelon (EXC) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
SMA 50/200 Cross
On the daily chart, this is the strongest risk-adjusted edge we found for Exelon (EXC) over ~53.1 years — trailing buy-and-hold by 2.1% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | SMA 50/200 Cross ✓ | Daily | 8.2% | 0.55 | -52.5% | 42.4% | 33 | -2.1% |
| 2 | EMA 50/200 Cross ✓ | Daily | 7.7% | 0.52 | -43.4% | 34.3% | 35 | -2.6% |
| 3 | EMA 20/50 Cross ✓ | Weekly | 7.7% | 0.51 | -51.1% | 56.5% | 23 | -2.6% |
| 4 | EMA 20/50 Cross ✓ | Daily | 6.6% | 0.48 | -56.1% | 40.7% | 108 | -3.7% |
| 5 | RSI Trend (>50) ✓ | Weekly | 6.6% | 0.47 | -48.1% | 43.6% | 140 | -3.7% |
| 6 | ADX / DMI ✓ | Weekly | 5.6% | 0.46 | -34.3% | 52.3% | 86 | -4.7% |
| 7 | Donchian Breakout | Daily | 4.8% | 0.41 | -65.8% | 45.3% | 190 | -5.5% |
| 8 | Stochastic ✓ | Daily | 4.9% | 0.39 | -50.1% | 71.0% | 252 | -5.5% |
| 9 | Rate of Change ✓ | Weekly | 5.2% | 0.39 | -48.6% | 45.5% | 167 | -5.1% |
| 10 | MACD ✓ | Weekly | 4.9% | 0.37 | -52.5% | 48.7% | 115 | -5.4% |
| 11 | Bollinger Breakout ✓ | Weekly | 4.1% | 0.37 | -40.3% | 54.0% | 50 | -6.2% |
| 12 | Donchian Midline ✓ | Weekly | 4.9% | 0.37 | -55.1% | 46.7% | 152 | -5.4% |
| 13 | Donchian Breakout | Weekly | 4.3% | 0.36 | -56.6% | 47.6% | 42 | -6.0% |
| 14 | EMA-10 Trend ✓ | Weekly | 3.9% | 0.32 | -67.5% | 50.6% | 257 | -6.4% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Exelon (EXC), SMA 50/200 Cross on the daily timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.